Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians.
OBJECTIVES:Parental consent for the participation of their neonate in neonatal research is influenced by the quality of the information delivered and the interaction between parents and investigators. Failure to provide important information may lead to difficulties in the decision making process of...
Main Authors: | Virginia Neyro, Valéry Elie, Nicole Thiele, Evelyne Jacqz-Aigrain |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5999079?pdf=render |
Similar Items
-
A Delphi process to optimize quality and performance of drug evaluation in neonates.
by: Frederic Legrand, et al.
Published: (2014-01-01) -
Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
by: Stéphanie Leroux, et al.
Published: (2021-04-01) -
Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review
by: Beate Aurich, et al.
Published: (2021-05-01) -
Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.
by: Emilie Desselas, et al.
Published: (2017-01-01) -
Errors in Clinician–Parent Communication during Neonatal Hospitalization
by: John M. Idso, et al.
Published: (2019-06-01)